Blood Glucose Device Market to Reach US$ 34.23 Billion by 2034 Driven by CGM Innovation

Blood Glucose Device Market Size and Forecast 2026-2034

According to a new study by Renub Research, the Blood Glucose Device Market is anticipated to grow from US$ 18.45 billion in 2025 to US$ 34.23 billion by 2034 at a Compound Annual Growth Rate (CAGR) of 7.11% during 2026-2034. Increasing prevalence of diabetes, adoption of self-testing, and advancements like CGMs, smart phones connected meters, and single-use sensors are boosting the growth of the market expansion.

Blood Glucose Device Industry Overview

A blood glucose meter is a medical instrument that allows for measuring a person's blood glucose levels. It is primarily used by diabetics in order to keep track of their condition at all times. The most popular types of blood glucose meters include glucometers, continuous glucose meters (CGMs), test strips, and lancets. With a blood glucose monitor, diabetics can determine if their sugar levels are within normal ranges.

Blood glucose meters find extensive applications in medical facilities, clinics, pharmacies, and private households due to their convenience and effectiveness. For patients suffering from either Type 1 or Type 2 diabetes, the use of glucose meters is crucial since it enables one to detect complications at an early stage and take necessary actions to avoid kidney failure, heart diseases, and peripheral neuropathy.

The demand for blood glucose meters is steadily increasing around the world due to the increase in cases of diabetes and health consciousness. With the development of digital health services, blood glucose monitors have become even more accessible. Portable blood glucose meters and smartphone-connected monitors are now available anywhere in the world.

Request Sample Report: https://www.renub.com/request-sample-page.php?gturl=self-monitoring-blood-glucose-device-market-p.php

Diabetes statistics in 2024

·        The number of adults with diabetes has reached 589 million (20-79 years), which is one in nine.

·        The total number of adults with diabetes is expected to reach 853 million in 2050, which is one in eight.

·        Four out of five adults with diabetes (81%) come from low and middle-income countries.

·        In 2024, diabetes accounted for 3.4 million deaths, or one death per 9 seconds.

·        It is estimated that 43% of adults with diabetes (252 million people) remain undiagnosed, and almost 90% live in low and middle-income countries.

·        Diabetes cost the world's health budget approximately $1.015 trillion in 2024, a staggering 338% increase over the last 17 years.

·        Worldwide, there are 635 million adults with impaired glucose tolerance and 488 million adults with impaired fasting glucose (1 in 11) at risk of developing type 2 diabetes.

·        One in five newborns is affected by gestational diabetes.

Growth Drivers for the Blood Glucose Device Market

Developments in Blood Glucose Device Market

April 2025 – Dexcom Inc. got FDA approval for their new product Dexcom G7 15-day Continuous Glucose Monitoring system to help diabetic adults manage their sugar levels better. This gave a boost to Dexcom's marketing efforts in the US and helped expand their line of advanced CGMs.

March 2025 – Dexcom Inc. partnered with Apple and launched a glucose monitoring app called G6 Continuous Glucose Monitoring System on Apple's Health app. It can be accessed via iPhones to check one's glucose level conveniently.

November 2024 – Beurer India Pvt. Ltd. launched GL 22 Blood Glucose Monitor which was produced as part of the company's Make in India policy. It combined German precision engineering with customized specifications to cater to the requirements of Indian consumers.

In February 2024, Abbott Laboratories launched its new product FreeStyle Libre Pro which is used to monitor glucose level remotely by healthcare professionals. This unique technology provides an opportunity for remote patient care and intervention in order to reduce the risk of any possible problems.

The European Commission authorized the marketing approval of Senseonics' Eversense Continuous Glucose Monitoring System for use in Europe in October 2025 (European Commission Press Release, 2025). This approval represents a substantial milestone for Senseonics, enabling the company to access the lucrative European market and meet the rising demands for advanced glucose monitoring devices.

Medtronic successfully acquired Minimed Technologies, a pioneer in the manufacturing of continuous glucose monitoring devices, in May 2024, broadening the product offerings and market coverage in the sector (Medtronic Press Release, 2024). The acquisition was a major step towards positioning Medtronic among the leading players in the diabetes management space by presenting an array of solutions.

In March 2023, Abbott received FDA clearance for integrating the FreeStyle Libre 3 and FreeStyle Libre 2 integrated continuous glucose monitoring (iCGM) sensor systems with automated insulin delivery (AID) systems. Abbott is currently selling the FreeStyle Libre 3 and FreeStyle Libre 2 iCGM system sensors in the U.S., with approval for use in patients four years old and above.

Ascensia Diabetes Care Holdings AG, the producer of CONTOUR BGM device series, formed a global partnership with SNAQ, a mobile app providing nutritional information for patients with diabetes, in February 2023.

Growth Drivers for the Blood Glucose Device Market

Expansion of Over-the-Counter and Consumer-Centric Technologies

There is significant momentum in the market owing to the increasing availability of over-the-counter and easy-to-use glucose monitoring products. An instance of this is the launch of the OTC continuous glucose monitor, Stelo by Dexcom, in August 2024. The product caters to adults interested in easy glucose monitoring without a prescription. The trend allows for early detection of individuals at risk of prediabetes, helps health-aware people, and limits the need for visits to the doctor. Over-the-counter availability expands the scope of consumers, drives preventive healthcare initiatives, and narrows the divide between clinical and consumer wellness devices. With more manufacturers embracing streamlined purchasing systems, including pharmacies, online shopping portals, and insurance-backed retail stores, there will be heightened visibility and acceptance of the market. Combining real-time information exchange and digital health platforms makes it easier for users to handle glucose levels independently.

Government-Led Manufacturing Expansion and Incentive Programs

The role of government policies supporting the manufacture of medical devices within the domestic market is crucial in enhancing market growth. In March 2024, there were thirteen newly established manufacturing facilities within the Indian market, which manufactured 138 categories of medical devices including glucose monitors. This helps lower dependence on imported products, ensures better supply chain support, and ensures affordable costs through improved local manufacturing. Higher manufacturing capabilities lead to stiff competition and quick scaling up of advanced technologies such as Bluetooth glucose monitoring devices. Furthermore, favorable regulatory policies and reimbursement programs in Asia, Europe, and North America facilitate the widespread adoption of these home monitoring devices. The increasing demand for glucose meters in line with the increased cases of diabetes necessitates sustained supply through these government-supported programs.

Advancements in Continuous Glucose Monitoring and Global Product Launches

The swift evolution of technology, especially in CGM, is rapidly boosting the market's growth rate. Companies are launching products that can stay on for a long time, provide accurate measurements, and sync smoothly with smartphones to enhance diabetes care. For example, Dexcom introduced Dexcom ONE+ in February 2024 in Belgium, Spain, and Poland, expanding its market presence with an advanced version of the CGM system that offers easy-to-use design and clinical information. Global launches of these products make them easily accessible and foster competition, which makes it easier for patients to switch from conventional finger pricking to wearable products. Real-time alerts, cloud-based data sharing, and artificial intelligence-supported analysis also appeal to health care providers looking for devices to help them get better results. With the integration of CGMs into non-invasive systems and connected insulin dispensers, they facilitate comprehensive diabetes management.

Segment Analysis

Blood Glucose Test Strips Market

The blood glucose test strips are considered among the most critical segments of the diabetes market, considering that these products are used on a daily basis. Test strips are required together with the glucose meters to measure the blood glucose level. The market will continue growing because of the increasing rates of people having diabetes, especially among elderly patients as well as those who lead sedentary lives. Greater consciousness about self-management of the condition has played an important role too. There has been considerable demand for blood glucose test strips from hospitals, clinics, and home healthcare facilities. Technical innovations have helped improve the accuracy of readings along with the reduced amount of blood needed for testing. Other factors such as support from governments and coverage of insurance companies have made these strips more accessible to patients. Considering the growing interest in preventive healthcare services, the market is forecast to grow in the future.

Blood Glucose Lancets Market

The Blood Glucose Lancets Market holds great importance in managing diabetes since the devices offer patients an easy and safe way to draw their blood when conducting glucose tests. Blood glucose lancets refer to small medical instruments designed to create a cut on the patient's body and collect blood for the test. The high rate of diabetes cases globally is contributing greatly to the increase in the demand for blood glucose lancets in health facilities as well as in homes. Other factors influencing the growth of this market include the preference for less painful and efficient devices and increased adoption of safety lancets with only one-time use. Efforts are being made to develop lancets with thin needles and advanced penetration technology for more comfort. Improved awareness of frequent glucose tests and widespread distribution of diabetic care products contribute to the growth of this market.

Type 2 Diabetes Blood Glucose Device Market

The market for type 2 diabetes blood glucose devices is growing at a fast rate owing to the increase in the prevalence of type 2 diabetes in the global population. It is the most prevalent type of diabetes across the world. Blood glucose devices include glucose meters and continuous glucose monitoring systems. These are highly important when it comes to monitoring sugar levels in type 2 diabetic patients and ensuring effective treatments. The leading cause behind an increase in the type 2 diabetes patient population includes lifestyle alterations, obesity, unhealthy dietary intake, and less physical activities. This helps in contributing immensely towards the demand from the global diabetes blood glucose devices market. Growing emphasis by healthcare professionals on self-monitoring is likely to play a key role in preventing complications and managing the condition effectively.

Blood Glucose Device Retail Pharmacies Market

The retail pharmacies have been identified as an important distribution channel for the sale of glucose monitors in the market. They provide access to products that play a crucial role in managing diabetes. Products like glucose meter, test strip, lancet, and accessories used with glucose monitor are extensively available via retail pharmacies. There is an increase in the diabetic patients' base that drives the growth in the market owing to easy accessibility. Professional support provided at these retail pharmacies, along with ease in access of the product, drives purchase. The retail pharmacies, both chain and independent, make the market grow, especially in urban and semi-urban areas. Collaboration of the pharmacies with healthcare providers is expected to drive the management of diabetes care and educating patients. With an increase in the demand for homecare solutions, retail pharmacies continue to play an important role in the market.

Ask Analyst for Customization in Report: https://www.renub.com/request-customization-page.php?gturl=self-monitoring-blood-glucose-device-market-p.php

Country Analysis

United States Blood Glucose Device Market

The United States represents one of the biggest and most developed markets for blood glucose monitors. The high incidence of diabetes, the wide popularity of CGM devices, and the quick advancement of technology fuel market growth. The debut of the new OTC Stelo by Dexcom also expands opportunities for preventive and wellness customers. Well-established reimbursement schemes, a developed digital healthcare system, and the popularity of insulin pump devices contribute to the integration of glucose devices with automated delivery. Market development via retail channels including pharmacies, health insurance companies, and online vendors increases sales. Government efforts to encourage chronic disease management and self-monitoring raise the need for blood glucose monitors. In the face of fierce competition from industry giants like Abbott, Dexcom, and Medtronic, the American market represents an innovation center.

Germany Blood Glucose Device Market

Germany is considered one of the most well-regulated markets in Europe regarding blood glucose testing equipment, thanks to the favorable insurance reimbursements as well as the adoption of advanced diabetes devices. There has been significant adoption of CGM due to the availability of good policies and the doctors' preference for CGM than other types of blood glucose testing devices. The integration of digital health solutions is becoming increasingly common via the use of approved medical apps in addition to the DiGA model. The growing elderly population together with the rising incidences of Type 2 diabetes in Germany is boosting demand for efficient monitoring solutions.

China Blood Glucose Device Market

The market for China’s Blood Glucose Meters is experiencing a significant boost due to high incidences of diabetes, better access to medical services, and robust government policies that promote chronic conditions management. The growing disposable incomes and health consciousness are boosting the sales of conventional and continuous glucose monitors. The production capacity of local manufacturers is increasing, which is helping the affordability of blood glucose meters. Online platforms are playing an important role in their supply, particularly in semi-urban and rural areas. The promotion of early detection and self-testing by the government contributes to the growing need. The products of foreign companies are facing tough competition from local suppliers, who offer affordable products with smartphone compatibility.

Saudi Arabia Blood Glucose Device Market

The market in Saudi Arabia is experiencing growth, thanks to high levels of obesity and Type 2 diabetes, some of the highest in the region. Investment in medical innovation as part of the Vision 2030 plan has increased uptake of technology innovations for glucose testing. Both public and private health facilities in Saudi Arabia have focused on promoting early screening and home glucose monitoring, thus increasing the need for glucose monitors and CGMs. Awareness campaigns have made people become more aware of the need to monitor their blood glucose levels. There has been increased government financing of diabetes care, resulting in more access to advanced technology. Leading global brands are well established in the market, although local distributors continue to increase access to retailers.

Market Segments

Product

·        Test Strips

·        Lancets

·        Blood Glucose Meters

Application

·        Type 1 Diabetes

·        Type 2 Diabetes

·        Gestational Diabetes

End User

·        Hospital Pharmacies

·        Retail Pharmacies

·        Online Sales

·        Diabetes Clinics & Centers

Countries

North America

·        United States

·        Canada

Europe

·        France

·        Germany

·        Italy

·        Spain

·        United Kingdom

·        Belgium

·        Netherlands

·        Turkey

Asia Pacific

·        China

·        Japan

·        India

·        Australia

·        South Korea

·        Thailand

·        Malaysia

·        Indonesia

·        New Zealand

Latin America

·        Brazil

·        Mexico

·        Argentina

Middle East & Africa

·        South Africa

·        Saudi Arabia

·        UAE

All companies have been covered with 5 Viewpoints

·        Overviews

·        Key Person

·        Recent Developments

·        SWOT Analysis

·        Revenue Analysis

Key Players Analysis

·        Abbott Laboratories

·        Medtronic

·        Dexcom, Inc.

·        B. Braun Melsungen AG

·        DarioHealth Corp

·        Sanofi

·        Bionime Corporation

·        Novo Nordisk

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.    

Contact Us:

Company Name: Renub Research

Contact Person: Rajat Gupta

Phone No: (D) +91-120-421-9822 (IND)

Website: https://www.renub.com/

Email: rajat@renub.com